CUSIP 03969K108COMARQTQ4 2025
59 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 11.96M | $347.43M |
| 2 | Frazier Life Sciences Management, L.P. | 9.87M | $286.76M |
| 3 | Blackrock, Inc. | 9.10M | $264.25M |
| 4 | Rubric Capital Management LP | 8.27M | $240.21M |
| 5 | Vanguard Group Inc | 7.25M | $210.65M |
| 6 | Jennison Associates LLC | 6.76M | $196.25M |
| 7 | Polar Capital Holdings PLC | 5.56M | $161.35M |
| 8 | State Street Corp | 5.49M | $159.38M |
| 9 |
| 4 | Oct 6, 2025 | Jennison Associates LLC | 13G/A | 10.2% | 12.25M | SEC |
| 5 | Aug 20, 2025 | Frazier Life Sciences Viii, L.P. | 13D/A | 7.5% | — | SEC |
| 6 | Aug 14, 2025 | Polar Capital Holdings PLC | 13G/A | 4.2% | 5.01M | SEC |
| 7 | May 15, 2025 | Polar Capital Holdings PLC | 13G/A | 5.7% | 6.71M | SEC |
| 8 | May 15, 2025 | Prudential Financial Inc | 13G/A | 10.1% | 11.95M | SEC |
| 9 | May 8, 2025 | Jennison Associates LLC | 13G/A | 9.6% | 177.68M | SEC |
| 10 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | 0.2% | 247.1K | SEC |
See the full Schedule 13D/13G history for Arcutis Biotherapeutics Inc.
Unlock full history| Gilder Gagnon Howe & Co LLC |
| 4.45M |
| $129.34M |
| 10 | Morgan Stanley | 4.34M | $126.04M |